{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:21:15Z","timestamp":1783707675966,"version":"3.55.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["1412200075"],"award-info":[{"award-number":["1412200075"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s13346-023-01487-5","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T16:02:10Z","timestamp":1703174530000},"page":"1820-1838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Co-delivery of indomethacin and uricase as a new strategy for inflammatory diseases associated with high uric acid"],"prefix":"10.1007","volume":"14","author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenshi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2559-2004","authenticated-orcid":false,"given":"Chao","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"issue":"3","key":"1487_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1042\/bj2350747","volume":"235","author":"KJ Davies","year":"1986","unstructured":"Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J. 1986;235(3):747\u201354. https:\/\/doi.org\/10.1042\/bj2350747.","journal-title":"Biochem J"},{"key":"1487_CR2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00378.2020","author":"M Furuhashi","year":"2020","unstructured":"Furuhashi M. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity. Am J Physiol-Endo M. 2020. https:\/\/doi.org\/10.1152\/ajpendo.00378.2020.","journal-title":"Am J Physiol-Endo M"},{"issue":"17","key":"1487_CR3","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.3390\/ijms22179221","volume":"22","author":"H Yanai","year":"2021","unstructured":"Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci. 2021;22(17):9221. https:\/\/doi.org\/10.3390\/ijms22179221.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1487_CR4","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/rheumatology\/keq204","volume":"49","author":"B \u00c1lvarez-Lario","year":"2010","unstructured":"\u00c1lvarez-Lario B, Macarr\u00f3n-Vicente J. Uric acid and evolution. Rheumatol. 2010;49(11):2010\u20135. https:\/\/doi.org\/10.1093\/rheumatology\/keq204.","journal-title":"Rheumatol"},{"issue":"4","key":"1487_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1021\/acs.biochem.5b01119","volume":"55","author":"T Hibi","year":"2016","unstructured":"Hibi T, Kume A, Kawamura A, Itoh T, Fukada H, Nishiya Y. Hyperstabilization of tetrameric Bacillus sp. TB-90 urate oxidase by introducing disulfide bonds through structural plasticity. Biochemistry. 2016;55(4):724\u201332. https:\/\/doi.org\/10.1021\/acs.biochem.5b01119.","journal-title":"Biochemistry"},{"key":"1487_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2018.10.007","volume":"278","author":"T Maruhashi","year":"2018","unstructured":"Maruhashi T, Hisatome I, Kihara Y, Higashi Y. Hyperuricemia and endothelial function: from molecular background to clinical perspectives. Atherosclerosis. 2018;278:226\u201331. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.10.007.","journal-title":"Atherosclerosis"},{"issue":"9","key":"1487_CR7","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/ndt\/gft029","volume":"28","author":"RJ Johnson","year":"2013","unstructured":"Johnson RJ, Nakagawa T, Jalal D, S\u00e1nchez-Lozada LG, Kang D-H, Ritz E. Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transpl. 2013;28(9):2221\u20138. https:\/\/doi.org\/10.1093\/ndt\/gft029.","journal-title":"Nephrol Dial Transpl"},{"issue":"15","key":"1487_CR8","doi-asserted-by":"publisher","first-page":"8849","DOI":"10.1111\/jcmm.15523","volume":"24","author":"H Zhang","year":"2020","unstructured":"Zhang H, Ma Y, Cao R, Wang G, Li S, Cao Y, Zhang H, Liu M, Liu G, Zhang J. Soluble uric acid induces myocardial damage through activating the NLRP3 inflammasome. J Cell Mol Med. 2020;24(15):8849\u201361. https:\/\/doi.org\/10.1111\/jcmm.15523.","journal-title":"J Cell Mol Med"},{"issue":"7081","key":"1487_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237\u201341. https:\/\/doi.org\/10.1038\/nature04516.","journal-title":"Nature"},{"issue":"11","key":"1487_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","volume":"13","author":"AK So","year":"2017","unstructured":"So AK, Martinon F. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol. 2017;13(11):639\u201347. https:\/\/doi.org\/10.1038\/nrrheum.2017.155.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"1487_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jare.2017.03.003","volume":"8","author":"R El Ridi","year":"2017","unstructured":"El Ridi R, Tallima H. Physiological functions and pathogenic potential of uric acid: a review. J Adv Res. 2017;8(5):487\u201393. https:\/\/doi.org\/10.1016\/j.jare.2017.03.003.","journal-title":"J Adv Res"},{"issue":"4","key":"1487_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MNH.0000000000000619","volume":"29","author":"TT Braga","year":"2020","unstructured":"Braga TT, Foresto-Neto O, Camara NOS. The role of uric acid in inflammasome-mediated kidney injury. Curr Opin Nephrol Hypertens. 2020;29(4):423\u201331. https:\/\/doi.org\/10.1097\/MNH.0000000000000619.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"11","key":"1487_CR13","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1080\/03007995.2016.1218840","volume":"32","author":"DI Jalal","year":"2016","unstructured":"Jalal DI. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review. Curr Med Res Opin. 2016;32(11):1863\u20139. https:\/\/doi.org\/10.1080\/03007995.2016.1218840.","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"1487_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380\u201390. https:\/\/doi.org\/10.1038\/s41584-020-0441-1.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1487_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/ndt\/gfu352","volume":"30","author":"J Jing","year":"2015","unstructured":"Jing J, Kielstein JT, Schultheiss UT, Sitter T, Titze SI, Schaeffner ES, McAdams-DeMarco M, Kronenberg F, Eckardt K-U, K\u00f6ttgen A. Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study. Nephrol Dial Transplant. 2015;30(4):613\u201321. https:\/\/doi.org\/10.1093\/ndt\/gfu352.","journal-title":"Nephrol Dial Transplant"},{"key":"1487_CR16","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S327378","author":"Y Peng","year":"2021","unstructured":"Peng Y, Ao M, Dong B, Jiang Y, Yu L, Chen Z, Hu C, Xu R. Anti-inflammatory effects of curcumin in the inflammatory diseases: status, limitations and countermeasures. Drug Des Dev Ther. 2021. https:\/\/doi.org\/10.2147\/DDDT.S327378.","journal-title":"Drug Des Dev Ther"},{"issue":"5","key":"1487_CR17","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","volume":"2","author":"V Kl\u00fcck","year":"2020","unstructured":"Kl\u00fcck V, Tim L, Janssen M, Comarniceanu A, Efd\u00e9 M, Tengesdal IW, Schraa K, Cleophas MC, Scribner CL, Skouras DB. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol. 2020;2(5):e270\u201380. https:\/\/doi.org\/10.1016\/S2665-9913(20)30065-5.","journal-title":"Lancet Rheumatol"},{"issue":"7","key":"1487_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-018-3686-8","volume":"24","author":"M-B S\u00e1rosi","year":"2018","unstructured":"S\u00e1rosi M-B. Binding of indomethacin methyl ester to cyclooxygenase-2. A computational study. J Mol Model. 2018;24(7):1\u20138. https:\/\/doi.org\/10.1007\/s00894-018-3686-8.","journal-title":"J Mol Model"},{"issue":"4","key":"1487_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3810\/pgm.2014.07.2787","volume":"126","author":"S Nalamachu","year":"2014","unstructured":"Nalamachu S, Wortmann R. Role of indomethacin in acute pain and inflammation management: a review of the literature. Postgrad Med. 2014;126(4):92\u20137. https:\/\/doi.org\/10.3810\/pgm.2014.07.2787.","journal-title":"Postgrad Med"},{"key":"1487_CR20","doi-asserted-by":"publisher","first-page":"e08973","DOI":"10.7554\/eLife.08973","volume":"4","author":"X Liang","year":"2015","unstructured":"Liang X, Bittinger K, Li X, Abernethy DR, Bushman FD, FitzGerald GA. Bidirectional interactions between indomethacin and the murine intestinal microbiota. Elife. 2015;4:e08973. https:\/\/doi.org\/10.7554\/eLife.08973.","journal-title":"Elife"},{"issue":"2","key":"1487_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3165\/jjpn.cr.2019.0170","volume":"33","author":"T Tominaga","year":"2020","unstructured":"Tominaga T, Omori S, Awazu M. Hypertension in a preterm after indomethacin use for patent ductus arteriosus. J Pediatric Nephrol. 2020;33(2):139\u201342. https:\/\/doi.org\/10.3165\/jjpn.cr.2019.0170.","journal-title":"J Pediatric Nephrol"},{"issue":"13","key":"1487_CR22","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","volume":"378","author":"WB White","year":"2018","unstructured":"White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, Hunt B, Castillo M, Gunawardhana L. Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med. 2018;378(13):1200\u201310. https:\/\/doi.org\/10.1056\/NEJMoa1710895.","journal-title":"N Engl J Med"},{"issue":"1","key":"1487_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/rheumatology\/key245","volume":"58","author":"R Terkeltaub","year":"2019","unstructured":"Terkeltaub R, Saag KG, Goldfarb DS, Baumgartner S, Schechter BM, Valiyil R, Jalal D, Pillinger M, White WB. Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout. Rheumatology. 2019;58(1):61\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/key245.","journal-title":"Rheumatology"},{"issue":"11","key":"1487_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/13543776.2019.1676727","volume":"29","author":"Y Dong","year":"2019","unstructured":"Dong Y, Zhao T, Ai W, Zalloum WA, Kang D, Wu T, Liu X, Zhan P. Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016\u20132019). Expert Opin Ther Pat. 2019;29(11):871\u20139. https:\/\/doi.org\/10.1080\/13543776.2019.1676727.","journal-title":"Expert Opin Ther Pat"},{"issue":"7","key":"1487_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/jama.2011.1169","volume":"306","author":"JS Sundy","year":"2011","unstructured":"Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, V\u00e1zquez-Mellado J, White WB, Lipsky PE, Horowitz Z. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA. 2011;306(7):711\u201320. https:\/\/doi.org\/10.1001\/jama.2011.1169.","journal-title":"JAMA"},{"key":"1487_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2147\/TCRM.S6043","volume":"6","author":"MK Reinders","year":"2010","unstructured":"Reinders MK, Tim L. New advances in the treatment of gout: review of pegloticase. Ther Clin Risk Manag. 2010;6:543. https:\/\/doi.org\/10.2147\/TCRM.S6043.","journal-title":"Ther Clin Risk Manag"},{"issue":"9","key":"1487_CR27","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","volume":"5","author":"AM Vargason","year":"2021","unstructured":"Vargason AM, Anselmo AC, Mitragotri S. The evolution of commercial drug delivery technologies. Nat Biomed Eng. 2021;5(9):951\u201367. https:\/\/doi.org\/10.1038\/s41551-021-00698-w.","journal-title":"Nat Biomed Eng"},{"key":"1487_CR28","first-page":"S24","volume-title":"Therapeutic approaches in the treatment of gout","author":"MH Pillinger","year":"2020","unstructured":"Pillinger MH, Mandell BF. Therapeutic approaches in the treatment of gout. Semin Arthritis Rheum: Elsevier; 2020. p. S24\u201330."},{"issue":"4","key":"1487_CR29","doi-asserted-by":"publisher","first-page":"101719","DOI":"10.1016\/j.berh.2021.101719","volume":"35","author":"LK Stamp","year":"2021","unstructured":"Stamp LK, Farquhar H. Treatment advances in gout. Best Prac Res Clin Rheumatol. 2021;35(4):101719. https:\/\/doi.org\/10.1016\/j.berh.2021.101719.","journal-title":"Best Prac Res Clin Rheumatol"},{"issue":"1","key":"1487_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2217\/nnm-2018-0120","volume":"14","author":"F Farjadian","year":"2019","unstructured":"Farjadian F, Ghasemi A, Gohari O, Roointan A, Karimi M, Hamblin MR. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine. 2019;14(1):93\u2013126. https:\/\/doi.org\/10.2217\/nnm-2018-0120.","journal-title":"Nanomedicine"},{"issue":"6","key":"1487_CR31","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.3390\/ijms24065994","volume":"24","author":"B-K Jin","year":"2023","unstructured":"Jin B-K, Odongo S, Radwanska M, Magez S. Nanobodies: a review of generation, diagnostics and therapeutics. Int J Mol Sci. 2023;24(6):5994. https:\/\/doi.org\/10.3390\/ijms24065994.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1487_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nano.2012.05.013","volume":"9","author":"ML Etheridge","year":"2013","unstructured":"Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J. The big picture on small medicine: the state of nanomedicine products approved for use or in clinical trials. Nanomed-Nanotechnol. 2013;9(1):1. https:\/\/doi.org\/10.1016\/j.nano.2012.05.013.","journal-title":"Nanomed-Nanotechnol"},{"key":"1487_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.coph.2018.03.013","volume":"40","author":"MF Rai","year":"2018","unstructured":"Rai MF, Pham CT. Intra-articular drug delivery systems for joint diseases. Curr Opin Pharmacol. 2018;40:67\u201373. https:\/\/doi.org\/10.1016\/j.coph.2018.03.013.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"1487_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.joca.2017.10.003","volume":"26","author":"V Kraus","year":"2018","unstructured":"Kraus V, Conaghan PG, Aazami H, Mehra P, Kivitz A, Lufkin J, Hauben J, Johnson J, Bodick N. Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA). Osteoarthr Cartil. 2018;26(1):34\u201342. https:\/\/doi.org\/10.1016\/j.joca.2017.10.003.","journal-title":"Osteoarthr Cartil"},{"issue":"11","key":"1487_CR35","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2106\/JBJS.N.00918","volume":"97","author":"N Bodick","year":"2015","unstructured":"Bodick N, Lufkin J, Willwerth C, Kumar A, Bolognese J, Schoonmaker C, Ballal R, Hunter D, Clayman M. An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial. JBJS. 2015;97(11):877\u201388. https:\/\/doi.org\/10.2106\/JBJS.N.00918.","journal-title":"JBJS"},{"issue":"1","key":"1487_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40265-022-01821-0","volume":"83","author":"SJ Keam","year":"2023","unstructured":"Keam SJ. Ozoralizumab: first approval. Drugs. 2023;83(1):87\u201392. https:\/\/doi.org\/10.1007\/s40265-022-01821-0.","journal-title":"Drugs"},{"issue":"1\u20132","key":"1487_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ijpharm.2008.12.031","volume":"371","author":"Y Xiong","year":"2009","unstructured":"Xiong Y, Guo D, Wang L, Zheng X, Zhang Y, Chen J. Development of nobiliside A loaded liposomal formulation using response surface methodology. Int J Pharm. 2009;371(1\u20132):197\u2013203. https:\/\/doi.org\/10.1016\/j.ijpharm.2008.12.031.","journal-title":"Int J Pharm"},{"issue":"6","key":"1487_CR38","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.1021\/acsnano.9b09773","volume":"14","author":"M Agnoletti","year":"2020","unstructured":"Agnoletti M, Rodr\u00edguez-Rodr\u00edguez C, K\u0142odzi\u0144ska SN, Esposito TV, Saatchi K, M\u00f8rck Nielsen H, H\u00e4feli UO. Monosized polymeric microspheres designed for passive lung targeting: biodistribution and pharmacokinetics after intravenous administration. ACS Nano. 2020;14(6):6693\u2013706. https:\/\/doi.org\/10.1021\/acsnano.9b09773.","journal-title":"ACS Nano"},{"issue":"3","key":"1487_CR39","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.biomaterials.2006.07.046","volume":"28","author":"D Chandrasekar","year":"2007","unstructured":"Chandrasekar D, Sistla R, Ahmad FJ, Khar RK, Diwan PV. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats. Biomaterials. 2007;28(3):504\u201312. https:\/\/doi.org\/10.1016\/j.biomaterials.2006.07.046.","journal-title":"Biomaterials"},{"key":"1487_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11418-021-01571-5","volume":"76","author":"M He","year":"2022","unstructured":"He M, Hu C, Chen M, Gao Q, Li L, Tian W. Effects of Gentiopicroside on activation of NLRP3 inflammasome in acute gouty arthritis mice induced by MSU. J Nat Med. 2022;76:178\u201387. https:\/\/doi.org\/10.1007\/s11418-021-01571-5.","journal-title":"J Nat Med"},{"key":"1487_CR41","doi-asserted-by":"publisher","first-page":"108107","DOI":"10.1016\/j.intimp.2021.108107","volume":"100","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhu W, Lu D, Zhang C, Wang Y. Tetrahydropalmatine attenuates MSU crystal-induced gouty arthritis by inhibiting ROS-mediated NLRP3 inflammasome activation. Int Immunopharmacol. 2021;100:108107. https:\/\/doi.org\/10.1016\/j.intimp.2021.108107.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1487_CR42","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbrc.2017.05.139","volume":"489","author":"Y Feng","year":"2017","unstructured":"Feng Y, Sun F, Gao Y, Yang J, Wu G, Lin S, Hu J. Taurine decreased uric acid levels in hyperuricemic rats and alleviated kidney injury. Biochem Biophys Res Commun. 2017;489(3):312\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2017.05.139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1487_CR43","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1080\/13880209.2022.2147551","volume":"60","author":"N Li","year":"2022","unstructured":"Li N, Amatjan M, He P, Zhang B, Mai X, Jiang Q, Xie H, Shao X. Integration of network pharmacology and intestinal flora to investigate the mechanism of action of Chinese herbal Cichorium intybus formula in attenuating adenine and ethambutol hydrochloride-induced hyperuricemic nephropathy in rats. Pharm Biol. 2022;60(1):2338\u201354. https:\/\/doi.org\/10.1080\/13880209.2022.2147551.","journal-title":"Pharm Biol"},{"issue":"3","key":"1487_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0006-2952(98)00303-7","volume":"57","author":"M-N Giraud","year":"1999","unstructured":"Giraud M-N, Motta C, Romero JJ, Bommelaer G, Lichtenberger LM. Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs). Biochem Pharmacol. 1999;57(3):247\u201354. https:\/\/doi.org\/10.1016\/S0006-2952(98)00303-7.","journal-title":"Biochem Pharmacol"},{"issue":"18","key":"1487_CR45","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3748\/wjg.v18.i18.2147","volume":"18","author":"K Takeuchi","year":"2012","unstructured":"Takeuchi K. Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility. World J Gastroenterol. 2012;18(18):2147. https:\/\/doi.org\/10.3748\/wjg.v18.i18.2147.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1487_CR46","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/ATVBAHA.119.313224","volume":"40","author":"Y Kimura","year":"2020","unstructured":"Kimura Y, Yanagida T, Onda A, Tsukui D, Hosoyamada M, Kono H. Soluble uric acid promotes atherosclerosis via AMPK (AMP-activated protein kinase)-mediated inflammation. Arterioscler Throm Vasc Biol. 2020;40(3):570\u201382. https:\/\/doi.org\/10.1161\/ATVBAHA.119.313224.","journal-title":"Arterioscler Throm Vasc Biol"},{"issue":"2","key":"1487_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41584-020-00544-4","volume":"17","author":"S Fillatreau","year":"2021","unstructured":"Fillatreau S, Manfroi B, D\u00f6rner T. Toll-like receptor signalling in B cells during systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(2):98\u2013108. https:\/\/doi.org\/10.1038\/s41584-020-00544-4.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1487_CR48","doi-asserted-by":"publisher","first-page":"e0193601","DOI":"10.1371\/journal.pone.0193601","volume":"13","author":"T Starr","year":"2018","unstructured":"Starr T, Bauler TJ, Malik-Kale P, Steele-Mortimer O. The phorbol 12-myristate-13-acetate differentiation protocol is critical to the interaction of THP-1 macrophages with Salmonella Typhimurium. PLoS ONE. 2018;13(3):e0193601. https:\/\/doi.org\/10.1371\/journal.pone.0193601.","journal-title":"PLoS ONE"},{"key":"1487_CR49","doi-asserted-by":"publisher","unstructured":"Van De Vlekkert D, Machado E, d\u2019Azzo A. Analysis of generalized fibrosis in mouse tissue sections with Masson\u2019s trichrome staining. Bio-protocol. 2020;10(10):e3629\u2013e3629. https:\/\/doi.org\/10.21769\/BioProtoc.3629.","DOI":"10.21769\/BioProtoc.3629"},{"key":"1487_CR50","doi-asserted-by":"publisher","first-page":"105209","DOI":"10.1016\/j.phrs.2020.105209","volume":"161","author":"P Balakumar","year":"2020","unstructured":"Balakumar P, Alqahtani A, Khan NA, Mahadevan N, Dhanaraj SA. Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: pathologic implications and putative pharmacologic targets. Pharmacol Res. 2020;161:105209. https:\/\/doi.org\/10.1016\/j.phrs.2020.105209.","journal-title":"Pharmacol Res"},{"issue":"5","key":"1487_CR51","doi-asserted-by":"publisher","first-page":"e0198197","DOI":"10.1371\/journal.pone.0198197","volume":"13","author":"A Kumar AU","year":"2018","unstructured":"Kumar AU A, Browne LD, Li X, Adeeb F, Perez-Ruiz F, Fraser AD, Stack AG. Temporal trends in hyperuricaemia in the Irish health system from 2006\u20132014: a cohort study. PLoS ONE. 2018;13(5):e0198197. https:\/\/doi.org\/10.1371\/journal.pone.0198197.","journal-title":"PLoS ONE"},{"issue":"1","key":"1487_CR52","doi-asserted-by":"publisher","first-page":"1874652","DOI":"10.1080\/16549716.2021.1874652","volume":"14","author":"Y Li","year":"2021","unstructured":"Li Y, Shen Z, Zhu B, Zhang H, Zhang X, Ding X. Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis. Glob Health Action. 2021;14(1):1874652. https:\/\/doi.org\/10.1080\/16549716.2021.1874652.","journal-title":"Glob Health Action"},{"issue":"3","key":"1487_CR53","doi-asserted-by":"publisher","first-page":"e043917","DOI":"10.1136\/bmjopen-2020-043917","volume":"11","author":"Z Wan","year":"2021","unstructured":"Wan Z, Song L, Hu L, Lei X, Huang Y, Lv Y. Temporal trends in hyperuricaemia among adults in Wuhan city, China, from 2010 to 2019: a cross-sectional study. BMJ Open. 2021;11(3):e043917. https:\/\/doi.org\/10.1136\/bmjopen-2020-043917.","journal-title":"BMJ Open"},{"issue":"9","key":"1487_CR54","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1097\/HJH.0000000000000701","volume":"33","author":"C Borghi","year":"2015","unstructured":"Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, Manolis AJ, Perez-Ruiz F, Mancia G. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33(9):1729\u201341. https:\/\/doi.org\/10.1097\/HJH.0000000000000701.","journal-title":"J Hypertens"},{"issue":"sup3","key":"1487_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/03007995.2017.1378523","volume":"33","author":"R Pontremoli","year":"2017","unstructured":"Pontremoli R. The role of urate-lowering treatment on cardiovascular and renal disease: evidence from CARES, FAST, ALL-HEART, and FEATHER studies. Curr Med Res Opin. 2017;33(sup3):27\u201332. https:\/\/doi.org\/10.1080\/03007995.2017.1378523.","journal-title":"Curr Med Res Opin"},{"key":"1487_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.006","volume":"80","author":"C Borghi","year":"2020","unstructured":"Borghi C, Agabiti-Rosei E, Johnson RJ, Kielstein JT, Lurbe E, Mancia G, Redon J, Stack AG, Tsioufis KP. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. Eur J Intern Med. 2020;80:1\u201311. https:\/\/doi.org\/10.1016\/j.ejim.2020.07.006.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"1487_CR57","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S2665-9913(20)30221-6","volume":"3","author":"R Hansildaar","year":"2021","unstructured":"Hansildaar R, Vedder D, Baniaamam M, Tausche A-K, Gerritsen M, Nurmohamed MT. Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout. Lancet Rheumatol. 2021;3(1):e58\u201370. https:\/\/doi.org\/10.1016\/S2665-9913(20)30221-6.","journal-title":"Lancet Rheumatol"},{"key":"1487_CR58","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.2147\/JIR.S329800","volume":"14","author":"Z Gong","year":"2021","unstructured":"Gong Z, Xia L, Xu R, Luo M, Deng H, Kang Z, Liu L, Liu Y, Zhang F, Shi J. The clinical effects of febuxostat alone or combined with arthroscopic surgery for gout: a single-center retrospective study. J Inflamm Res. 2021;14:4509. https:\/\/doi.org\/10.2147\/JIR.S329800.","journal-title":"J Inflamm Res"},{"issue":"1","key":"1487_CR59","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41392-023-01364-0","volume":"8","author":"L Liu","year":"2023","unstructured":"Liu L, Liu X, Xin W, Zhou L, Huang B, Han C, Cao Z, Hua Z. A bacteria-based system expressing anti-TNF-\u03b1 nanobody for enhanced cancer immunotherapy. Signal Transduct Target Ther. 2023;8(1):134. https:\/\/doi.org\/10.1038\/s41392-023-01364-0.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"1487_CR60","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1021\/acsnano.0c01676","volume":"14","author":"J Guo","year":"2020","unstructured":"Guo J, Yu Z, Das M, Huang L. Nano codelivery of oxaliplatin and folinic acid achieves synergistic chemo-immunotherapy with 5-fluorouracil for colorectal cancer and liver metastasis. ACS Nano. 2020;14(4):5075\u201389. https:\/\/doi.org\/10.1021\/acsnano.0c01676.","journal-title":"ACS Nano"},{"issue":"5","key":"1487_CR61","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.7150\/thno.68563","volume":"12","author":"G Gong","year":"2022","unstructured":"Gong G, Pan J, He Y, Shang J, Wang X, Zhang Y, Zhang G, Wang F, Zhao G, Guo J. Self-assembly of nanomicelles with rationally designed multifunctional building blocks for synergistic chemo-photodynamic therapy. Theranostics. 2022;12(5):2028. https:\/\/doi.org\/10.7150\/thno.68563.","journal-title":"Theranostics"},{"key":"1487_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biomaterials.2016.04.001","volume":"94","author":"Z-T Cao","year":"2016","unstructured":"Cao Z-T, Chen Z-Y, Sun C-Y, Li H-J, Wang H-X, Cheng Q-Q, Zuo Z-Q, Wang J-L, Liu Y-Z, Wang Y-C. Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles. Biomaterials. 2016;94:9\u201319. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.04.001.","journal-title":"Biomaterials"},{"issue":"11","key":"1487_CR63","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1016\/j.apsb.2021.05.004","volume":"11","author":"Z Tang","year":"2021","unstructured":"Tang Z, Xiao Y, Kong N, Liu C, Chen W, Huang X, Xu D, Ouyang J, Feng C, Wang C. Nano-bio interfaces effect of two-dimensional nanomaterials and their applications in cancer immunotherapy. Acta Pharma Sin B. 2021;11(11):3447\u201364. https:\/\/doi.org\/10.1016\/j.apsb.2021.05.004.","journal-title":"Acta Pharma Sin B"},{"issue":"9","key":"1487_CR64","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/pharmaceutics13091433","volume":"13","author":"I Gaurav","year":"2021","unstructured":"Gaurav I, Wang X, Thakur A, Iyaswamy A, Thakur S, Chen X, Kumar G, Li M, Yang Z. Peptide-conjugated nano delivery systems for therapy and diagnosis of cancer. Pharmaceutics. 2021;13(9):1433. https:\/\/doi.org\/10.3390\/pharmaceutics13091433.","journal-title":"Pharmaceutics"},{"issue":"10","key":"1487_CR65","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1166\/jbn.2021.3168","volume":"17","author":"T Han","year":"2021","unstructured":"Han T, Wang M, Li W, An M, Fu H. Bmk9 and uricase nanoparticle complex for the treatment of gouty arthritis and uric acid nephropathy. J Biomed Nanotechnol. 2021;17(10):2071\u201384. https:\/\/doi.org\/10.1166\/jbn.2021.3168.","journal-title":"J Biomed Nanotechnol"},{"issue":"1","key":"1487_CR66","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/medicina57010058","volume":"57","author":"AF Cicero","year":"2021","unstructured":"Cicero AF, Fogacci F, Kuwabara M, Borghi C. Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update. Medicina. 2021;57(1):58. https:\/\/doi.org\/10.3390\/medicina57010058.","journal-title":"Medicina"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01487-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-023-01487-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01487-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:41:54Z","timestamp":1717591314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-023-01487-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1487"],"URL":"https:\/\/doi.org\/10.1007\/s13346-023-01487-5","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]},"assertion":[{"value":"27 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the experimental protocols were approved by the Institutional Animal Care and Use Committee of China Pharmaceutical University (approval number 2019\u201306-005).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No human studies have been performed in this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}